CV Sciences (CVSI) Net Margin Growth (5y) (2018 - 2026)
CV Sciences (CVSI) Net Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,287.00 |
| Mar 31, 2026 | 4,443.00 |
| Dec 31, 2025 | 18,363.00 |
| Sep 30, 2025 | 4,501.00 |
| Jun 30, 2025 | 7,954.00 |
| Mar 31, 2025 | 5,927.00 |
| Dec 31, 2024 | 5,970.00 |
| Sep 30, 2024 | 224.00 |
| Jun 30, 2024 | -2,206.00 |
| Mar 31, 2024 | 4,724.00 |
| Dec 31, 2023 | -4,326.00 |
| Sep 30, 2023 | -3,516.00 |
| Jun 30, 2023 | -5,828.00 |
| Mar 31, 2023 | 12,989.00 |
| Dec 31, 2022 | -6,627.00 |
| Sep 30, 2022 | -1,693.00 |
| Jun 30, 2022 | -6,204.00 |
| Mar 31, 2022 | 5,299.00 |
| Dec 31, 2021 | -6,384.00 |
| Sep 30, 2021 | 6,387.00 |